Literature DB >> 2874618

The use of somatostatin and its analogs in the treatment of surgical disorders.

S Mulvihill, T N Pappas, E Passaro, H T Debas.   

Abstract

Somatostatin is a naturally occurring peptide with a wide spectrum of biologic actions, most of which are inhibitory in nature. It has wide distribution, and within the gastrointestinal tract is is found in the pancreas, the stomach, intestinal mucosa, and myenteric neurons. It appears to function as a classic circulating hormone, as well as both a paracrine or locally acting agent and a neurocrine agent. Because of its inhibitory actions on gut endocrine, secretory, and motor functions, it has potential applicability in the treatment of a variety of disorders of interest to the surgeon. Indeed, it has been used successfully in the management of upper gastrointestinal hemorrhage, secretory diarrhea, short bowel syndrome, pancreatitis, gastrointestinal fistulas, and peptide-secreting tumors of the gut (apudomas). This review discusses physiology, pathophysiology, and therapeutic applications of somatostatin that may be important in surgical practice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874618

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Somatostatin and the treatment of cancer.

Authors:  T N Pappas
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

Review 2.  Palliative care.

Authors:  C L Davis; J R Hardy
Journal:  BMJ       Date:  1994-05-21

3.  Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.

Authors:  B M Miller; L W Traverso; P C Freeny; N N Abumrad
Journal:  Int J Pancreatol       Date:  1989-02

4.  Congenital chylothorax treated with octreotide.

Authors:  Yasin Sahin; Derya Aydin
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

5.  Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.

Authors:  P Nubiola; J M Badia; F Martinez-Rodenas; M J Gil; M Segura; J Sancho; A Sitges-Serra
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

6.  The adverse effects of octreotide on the healing of colonic anastomoses in rats.

Authors:  A G Türkçapar; S Demirer; N Sengül; S Ersöz; E Kuterdem; N Renda; I Kuzu
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 7.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

8.  Effect of somatostatin on adenylate cyclase activity in normal and neoplastic thyroid tissue.

Authors:  A E Siperstein; K E Levin; E T Gum; O H Clark
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

9.  Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula.

Authors:  T Ohta; T Nagakawa; K Mori; M Kanno; M Kayahara; K Ueno; I Miyazaki
Journal:  Int J Pancreatol       Date:  1992-06

10.  Effect of octreotide (Sandostatin 201-995) on bile flow and bile components.

Authors:  M Sahin; A Kartal; M Belviranli; S Yol; F Aksoy; M Ak
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.